Riskpilot← Back to searchSign inGet full accessSP TOPCO I AS
ASActiveOrg 926681109Lilleakerveien 2B, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20210 employees
Revenue 2024
NOK 0
EBITDA margin
—
-281% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
NOK -120K
-281% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -120K | -281% |
| Net profit | NOK -120K | -281% |
| Total assets | NOK 135,9M | -22% |
| Equity | NOK 135,6M | -23% |
| Employees | 0 | — |
Legal name
SP TOPCO I AS
Org number
926681109
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
25. februar 2021
Share capital
NOK 66 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Å investere direkte eller indirekte i selskaper relatert til helsesektoren eller livsvitenskap, herunder gjennom deltagelse i hel- eller deleide selskaper eller andre sammenslutninger eller investeringer i andre finansielle instrumenter som direkte eller indirekte kan være egnet til å gi selskapet tilgang til investeringer relatert til helsesektoren, samt alt som står i forbindelse med dette.
Address
Lilleakerveien 2B, 0283 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | −6 | −50 | −32 | −120 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −6 | −50 | −32 | −120 |
| Net financials | −0 | 0 | 0 | 0 |
| Profit before tax | −6 | −50 | −32 | −120 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −6 | −50 | −32 | −120 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 75 044 | 90 194 | 175 142 | 135 934 |
| Equity | 75 024 | 90 125 | 175 015 | 135 625 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 20 | 69 | 127 | 309 |
| Total debt | 20 | 69 | 127 | 309 |
EBITDA margin
-12047200.0%
This company
15.8%
Market median
-76248201% vs market
20212024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20212024
Return on equity
-0.1%
This company
18.4%
Market median
-101% vs market
20212024
Net profit margin
-12047200.0%
This company
8.1%
Market median
-148730964% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2026 | |
| Chairman | 2022 | |
| Board of Directors | 2026 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 99% | 99% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Marylebone Holding As
SP TOPCO I AS Board members of SP TOPCO I AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christopher Segtnan Tangen | Chairman | 0 companies |
| Magne Stoknes | Board of Directors | 0 companies |
| Synne Hermansen Røine | Chairman | 0 companies |
| Joachim Andersen | Board of Directors | 0 companies |